Telemonitoring of Type 2 Diabetes Mellitus in Italy.

Source: Dario, C., et al. 2017 - Pubmed ID: 27379995

Setting: Italy,

Study design:



Follow up: 12 months

Patient group:

Sample size:

Total: 299(243)

IG: 208 (166)

CG: 91 (77)


Inclusion criteria:

  • Diabetes type2
  • HbA1c > 53mmol/mol (7.0%)
Type of technology:

Home monitoring

  • Glucometer
  • Home care portal (Gateway for data transmission)

Intervention: Patients monitored and transmitted data to an eHealth Center. Clinicians could access the Home Care portal any time and were informed when anomalies were detected, to take appropriate action.


Duration: NA

Add on: NA


Control group: Usual care

Clinical effect/ Patient safety:

Clinical effect:

  • HbA1c →
  • Physical Component Summary →
  • Mental Component Summary ↓ (worse)


Patient safety: NA

Patient experiences/ Staff experiences:

Patient experiences: NA

Staff experiences: NA

Costs and organization:



  • Blood glucose


Staff resources

  • Staff for monitoring clinical data


Organization: NA


Health care utilization:

  • Outpatient visits to diabetologists ↓
  • Planned hospitalization ↓
  • Emergency department visits →
  • Bed days for hospitalized patients →
Scroll to Top


“↑”: Statistically significant increase

“↓”: Statistically significant decrease

“→”: Statistically insignificant (no difference)